Contact
Please use this form to send email to PR contact of this press release:
Copiktra (duvelisib): Drug Safety Communication - FDA Warns about Possible Increased Risk of Death and Serious Side Effects
TO:
Please use this form to send email to PR contact of this press release:
Copiktra (duvelisib): Drug Safety Communication - FDA Warns about Possible Increased Risk of Death and Serious Side Effects
TO: